Zamora, C., Diaz-Torne, C., Ortiz, M., Moya, P., Park, H., Pitarch, C., . . . Vidal, S. (2025). Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis.
Citación estilo ChicagoZamora, C., et al. Platelet-Derived Soluble CD40L and Its Impact On Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis. 2025.
Cita MLAZamora, C., et al. Platelet-Derived Soluble CD40L and Its Impact On Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis. 2025.
Precaución: Estas citas no son 100% exactas.